Zehra Narlı Özdemir

8PUBLICATIONS
42CO-AUTHORS
Cell physiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsHaematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 11, 2026
FACIT-fatigue score and treatment quality assessment for paroxysmal nocturnal hemoglobinuria patients treated with Eculizumab in Türkiye.

|Aug 27, 2026
Elranatamab in Relapsed/Refractory Multiple Myeloma: A Multicenter Real-World Study from Türkiye.

|Mar 04, 2024
Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients.

Zehra Narlı Özdemir, Yıldız İpek, Püsem Patır

|Apr 09, 2021
Leukemic stem cells shall be searched in the bone marrow before "tyrosine kinase inhibitor-discontinuation" in chronic myeloid leukemia.

Osman Ilhan, Zehra Narli Ozdemir, Klara Dalva

|Oct 28, 2020
Highlighting the Prognostic Importance of Measurable Residual Disease Among Acute Myeloid Leukemia Risk Factors

Zehra Narlı Özdemir, Uğur Şahin, Klara Dalva

Pageof 2

Frequent Collaborators

2 joint publications

Cemaleddin Öztürk

2 joint publications

Muhit Özcan

2 joint publications

Ahmet Emre Eşkazan

1 joint publications

Işınsu Kuzu